Citadel Advisors’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7098 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7066 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7159 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6865 |
|
|
2023
Q2 | – | Sell |
-139
| Closed | -$3.84K | – | 6860 |
|
|
2023
Q1 | $3.84K | Sell |
139
-508
| -79% | -$14K | ﹤0.01% | 5635 |
|
|
2022
Q4 | $21.3K | Buy |
647
+508
| +365% | +$16.7K | ﹤0.01% | 5549 |
|
|
2022
Q3 | $17K | Buy |
139
+92
| +196% | +$11.3K | ﹤0.01% | 5572 |
|
|
2022
Q2 | $8K | Sell |
47
-1,641
| -97% | -$279K | ﹤0.01% | 5848 |
|
|
2022
Q1 | $489K | Buy |
1,688
+496
| +42% | +$144K | ﹤0.01% | 4470 |
|
|
2021
Q4 | $623K | Buy |
+1,192
| New | +$623K | ﹤0.01% | 4356 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7412 |
|
|
2021
Q2 | – | Sell |
-152
| Closed | -$181K | – | 7372 |
|
|
2021
Q1 | $181K | Buy |
+152
| New | +$181K | ﹤0.01% | 5483 |
|
|
2020
Q3 | – | Sell |
-400
| Closed | -$900K | – | 5484 |
|
|
2020
Q2 | $900K | Buy |
+400
| New | +$900K | ﹤0.01% | 2947 |
|